Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA DR. REDDYS LAB GLENMARK PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -31.4 19.7 - View Chart
P/BV x 2.9 4.4 64.4% View Chart
Dividend Yield % 0.3 0.6 40.2%  

Financials

 GLENMARK PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
DR. REDDYS LAB
Mar-23
GLENMARK PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4874,656 10.5%   
Low Rs3493,788 9.2%   
Sales per share (Unadj.) Rs460.41,481.4 31.1%  
Earnings per share (Unadj.) Rs13.4270.7 4.9%  
Cash flow per share (Unadj.) Rs35.0345.7 10.1%  
Dividends per share (Unadj.) Rs2.5040.00 6.3%  
Avg Dividend yield %0.60.9 63.1%  
Book value per share (Unadj.) Rs335.11,389.6 24.1%  
Shares outstanding (eoy) m282.17166.53 169.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.8 31.9%   
Avg P/E ratio x31.315.6 200.4%  
P/CF ratio (eoy) x11.912.2 97.7%  
Price / Book Value ratio x1.23.0 41.1%  
Dividend payout %18.714.8 126.5%   
Avg Mkt Cap Rs m117,953703,039 16.8%   
No. of employees `000NANA-   
Total wages/salary Rs m27,81046,466 59.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,901246,697 52.7%  
Other income Rs m3,16810,555 30.0%   
Total revenues Rs m133,069257,252 51.7%   
Gross profit Rs m15,12563,860 23.7%  
Depreciation Rs m6,11312,502 48.9%   
Interest Rs m3,4961,428 244.8%   
Profit before tax Rs m8,68560,485 14.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,91115,412 31.9%   
Profit after tax Rs m3,77445,073 8.4%  
Gross profit margin %11.625.9 45.0%  
Effective tax rate %56.525.5 221.9%   
Net profit margin %2.918.3 15.9%  
BALANCE SHEET DATA
Current assets Rs m98,737203,161 48.6%   
Current liabilities Rs m50,45585,721 58.9%   
Net working cap to sales %37.247.6 78.1%  
Current ratio x2.02.4 82.6%  
Inventory Days Days779 8.5%  
Debtors Days Days115107 107.4%  
Net fixed assets Rs m76,920112,638 68.3%   
Share capital Rs m282833 33.9%   
"Free" reserves Rs m94,281230,571 40.9%   
Net worth Rs m94,563231,404 40.9%   
Long term debt Rs m38,5211,278 3,014.2%   
Total assets Rs m175,658315,799 55.6%  
Interest coverage x3.543.4 8.0%   
Debt to equity ratio x0.40 7,376.0%  
Sales to assets ratio x0.70.8 94.7%   
Return on assets %4.114.7 28.1%  
Return on equity %4.019.5 20.5%  
Return on capital %9.226.6 34.4%  
Exports to sales %052.2 0.0%   
Imports to sales %016.8 0.0%   
Exports (fob) Rs mNA128,803 0.0%   
Imports (cif) Rs mNA41,484 0.0%   
Fx inflow Rs m46,464128,803 36.1%   
Fx outflow Rs m12,71241,484 30.6%   
Net fx Rs m33,75187,319 38.7%   
CASH FLOW
From Operations Rs m6,25458,875 10.6%  
From Investments Rs m-5,285-41,373 12.8%  
From Financial Activity Rs m-775-26,861 2.9%  
Net Cashflow Rs m325-9,073 -3.6%  

Share Holding

Indian Promoters % 46.7 26.7 175.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.7 47.3 73.3%  
FIIs % 23.7 28.6 82.8%  
ADR/GDR % 0.0 15.3 -  
Free float % 53.4 58.0 92.0%  
Shareholders   209,931 257,794 81.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Glenmark Pharma vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs Dr. Reddys Share Price Performance

Period Glenmark Pharma Dr. Reddys S&P BSE HEALTHCARE
1-Day -0.57% 1.78% 1.18%
1-Month 5.16% -4.23% -0.75%
1-Year 112.94% 35.93% 61.82%
3-Year CAGR 27.51% 10.85% 18.16%
5-Year CAGR 8.05% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.